stella
beta
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population — Stella
Recruiting
Back to Cataracts Infantile trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
Spain
Hospìtal Sant Joan de Deu, Barcelona
View full record on ClinicalTrials.gov